A new wave of vaccine distrust – why post-Covid attitudes are resulting in decreased routine vaccinations.
Routine vaccination for certain communicable diseases is an effective public health intervention that prevents the transmission of infectious diseases. So why is there is reduction in the uptake of routine childhood immunisations over recent years?
Can GLP-1 medication reduce the risk of Alzheimer’s Disease?
GLP-1 receptor agonists such as Semeglutide (Ozempic® and Wegovy®) are becoming a household name for weight-loss treatments for clinically obese patients, with 82% of adults having heard about GLP-1 medications. However, the benefits of GLP-1 medications are not just limited to
Is the term ‘obese’ outdated? New global report says yes!
With the huge success of the once-weekly injectable weight-loss treatments such as Ozempic® and Wegovy® over recent years to help combat the global ‘obesity’ epidemic; medical professionals have called for a new definition of the term ‘obese’. Despite individuals with higher
Why ‘Ozempic® shaming’ needs to stop
Ozempic® is a fairly new medication, being approved for use in 2017 for the treatment of diabetes and has also shown significant results when prescribed off-label for obese individuals who want to lose weight. The active ingredient in Ozempic®; Semaglutide,